Tuebingen, Germany

Ulrich Herrlinger


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ulrich Herrlinger: Innovator in Neural Stem Cell Therapy

Introduction

Ulrich Herrlinger is a notable inventor based in Tuebingen, Germany. He has made significant contributions to the field of medical science, particularly in the area of brain tumor therapy. With a total of two patents to his name, Herrlinger's work focuses on the innovative use of neural stem cells.

Latest Patents

Herrlinger's latest patents revolve around the use of neural stem cells for treating brain tumors. His invention is based on the surprising finding that these stem cells can migrate throughout a brain tumor and track metastatic brain tumor cells. The methods he developed involve administering genetically engineered neural stem cells to individuals affected by brain tumors. Additionally, he has outlined a method for preparing these genetically engineered neural stem cells and a composition that includes them in a pharmaceutically acceptable carrier.

Career Highlights

Throughout his career, Ulrich Herrlinger has worked with prominent organizations such as Children's Medical Center Corporation and The General Hospital Corporation. His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Some of Herrlinger's notable coworkers include Evan Y. Snyder and Xandra O. Breakefield. Their collaborative efforts have further enriched the research landscape in which Herrlinger operates.

Conclusion

Ulrich Herrlinger stands out as an innovator in the field of neural stem cell therapy, with his groundbreaking patents paving the way for new treatment options for brain tumors. His contributions to medical science are invaluable and continue to inspire future research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…